The landscape of research on ferroptosis under hypoxic conditions: a bibliometric analysis

Di Yu, Yibo Hu, Meijuan Ma, Wenjia Li, Xiaohui ZhaoFrontiers in Pharmacology 2025 · DOI

This bibliometric analysis maps the rapidly evolving intersection of ferroptosis—a specialized form of iron-dependent cell death—and hypoxia (low-oxygen conditions). By analyzing over a decade of literature, the authors identify a massive surge in research interest since 2019, dominated by Chinese institutions and focused on finding therapeutic targets for ischemia, heart disease, and cancer.

TL;DR

This paper provides a comprehensive "map" of the research landscape linking ferroptosis and hypoxia from 2013 to 2023. It reveals an exponential growth in publications, identifies China as the global leader in the field, and highlights ischemia-reperfusion injury and cancer therapy as the primary research hotspots.

What Problem Does This Paper Address?

Ferroptosis is a relatively "new" type of regulated cell death characterized by iron accumulation and lipid peroxidation. Because hypoxia is a hallmark of many lethal conditions—including strokes, heart attacks, and solid tumors—researchers have increasingly looked at how low oxygen levels trigger or inhibit ferroptosis.

However, as the volume of research explodes, it becomes difficult for scientists to see the "big picture." This paper addresses the need for a systematic, quantitative overview of the field. It identifies which countries are leading, which journals are most influential, and—most importantly—where the "knowledge gaps" and emerging trends lie.

Methods

The authors employed bibliometric analysis, a statistical approach to evaluate scientific literature.

  • Search Strategy: They queried the Web of Science Core Collection (WoSCC) for articles published between January 2013 and December 2023 using the keywords "Ferroptosis" and "Hypoxia."
  • Tools: Data was processed using Microsoft Excel 2019 for basic statistics and CiteSpace 6.3.R1 for advanced visualization.
  • Metrics: They analyzed "Centrality" (a measure of a node's influence in a network), citation bursts (rapid increases in citations for specific terms), and keyword clustering to identify research "hotspots."

Datasets

The primary dataset was extracted from the Web of Science Core Collection (WoSCC), specifically the Science Citation Index Expanded. After filtering for relevance and removing duplicates, the final analysis focused on 472 research papers (articles and reviews).

Key Insights and Ideas

  • The 2019 Tipping Point: Research remained stagnant for years (only 1–6 papers annually until 2018) before exploding. By 2023, the annual output reached 204 publications, suggesting the field has moved from niche discovery to a mainstream biomedical frontier.
  • Geographic Dominance: China is the undisputed leader in this niche, contributing 359 of the 472 analyzed papers. Wuhan University emerged as the top-producing institution.
  • From Mechanism to Medicine: Early research (2013–2017) focused on basic molecular biology (e.g., prolyl hydroxylases, c-myc). Current trends (2021–2023) have shifted toward clinical applications, specifically ischemia-reperfusion injury (IRI) and tumor microenvironments.
  • The Nrf2/HO-1 Axis: The analysis highlights the Nrf2/HO-1 signaling pathway as a critical "bridge" between hypoxia and ferroptosis, serving as a major focus for drug development.
  • High-Quality Venues: The research is not just high-volume but high-impact; nine of the top ten journals publishing in this area are ranked as Q1 (top 25% of their field).

Key Results

  • Total Publications: 472 papers.
  • Top Country: China (359 papers, Centrality: 0.24).
  • Top Institution: Wuhan University (23 papers).
  • Most Prolific Author: Claudiu T. Supuran (Florence University), known for work on carbonic anhydrase inhibitors in tumors.
  • Most Cited Work: The 2017 Cell review by Stockwell et al. remains the foundational text for the field, garnering the highest citation count within this specific subset of literature.
  • Top Journal: International Journal of Molecular Sciences (10 articles).

Limitations and Future Work

The authors acknowledge several limitations:

  1. Database Bias: By only using the Web of Science, the study may have missed relevant papers indexed in Scopus, PubMed, or regional databases like CNKI.
  2. Citation Lag: Because it takes 3–10 years for citations to peak, very recent (and potentially groundbreaking) papers may not yet show high "centrality" or citation counts.
  3. Language: The search was limited to English-language publications.

Future Directions: The paper suggests that future research will likely focus on "PANoptosis" (the crosstalk between ferroptosis, apoptosis, and necroptosis) and the development of highly specific inhibitors to prevent tissue damage during organ transplants and heart attacks.

Summary updated

Abstract

This study highlights key areas of interest and emerging trends in ferroptosis research in the presence of hypoxic conditions, thus providing valuable insights for future directions of exploration for the diagnosis and treatment of hypoxia-related diseases.
BibTeX
@inproceedings{yu2025landscape,
  author = {Di Yu and Yibo Hu and Meijuan Ma and Wenjia Li and Xiaohui Zhao},
  title = {{The landscape of research on ferroptosis under hypoxic conditions: a bibliometric analysis}},
  booktitle = {Frontiers in Pharmacology},
  year = {2025},
  doi = {10.3389/fphar.2025.1519000},
}
Figure